Ivantis Company
Ivantis, Inc. is a company focused on developing an innovative treatment for Glaucoma. It is their goal to develop a less invasive, more effective option for the 60+ million people worldwide suffering from Primary Open Angle Glaucoma. As they successfully address this initial goal, it is then there intention to focus on innovative development for the treatment of other debilitating diseases within ophthalmology.
Investors
Technology:
P4 Medicine
Industry:
Health Care, Health Diagnostics, Medical Device
Headquarters:
Irvine, California, United States
Founded Date:
2007-01-01
Employees Number:
101-250
Funding Status:
Late Stage Venture
Investors Number:
16
Total Funding:
$132.4M
Estimated Revenue:
$10M to $50M
Last Funding Type:
Series C
Register and Claim Ownership